-

Swoop Introduces New Products to Redefine Physician Engagement Beyond Typical 1:1 National Provider Identifier Targeting and Revolutionize Heath Care Provider Marketing

SAN FRANCISCO--(BUSINESS WIRE)--Swoop, the leader in AI-generated digital audiences for healthcare, today announced the release of its newest product offerings that uncover optimal healthcare provider (HCP) influencers for life sciences companies. This first-in-market approach re-imagines HCP targeting in digital advertising beyond conventional National Provider Identifier (NPI) targeting by applying machine learning and artificial intelligence (AI) against a proprietary real-world data universe to uncover HCPs with the highest propensity to be influential brand ambassadors.

"Swoop's approach improves on the current system because it accounts for real-world behavior to uncover the HCPs most meaningful to a brand, leading to increased reach and prescription lift,” said Swoop co-founder and President Ron Elwell. “Through this new set of offerings, we are able to explore the multi-dimensionality of HCP influence and surface a much more refined list of the truly influential HCPs – many of whom may never surface via conventional NPI marketing approaches – and avoid the suboptimal HCP response rates and ROI associated with traditional, volume-based 1:1 NPI targeting advertising.”

HCPs with the most influence are often undetected, such as senior physicians who may not directly write prescriptions, physicians who influence upstream from a prescribing NPI, or general practitioners who act as specialists. Swoop defines, discovers and scores a brand’s most influential HCPs by applying machine learning and AI against the social footprint and digital body language of millions of HCPs. This unique combination is made possible through the integration of Real Chemistry’s proprietary Healthcare Social Graph with Swoop’s proprietary real-world data universe. The result is three products that reach the following audiences:

  • Opinion Influencer Audiences: Identifies the most influential HCPs in a therapeutic area based on their social activity plus online activity plus referral activity plus patient activity.
  • High Prescriber Practice Affiliation Audiences: Reveals the top prescribing HCPs and targets applicable NPIs in their practice.
  • Hospitals and Integrated Delivery Network Affiliation Audiences: Uncovers and targets NPIs at any affiliation level, such as a hospital or integrated delivery network.

Through each of these products, clients can create HCP influencer audience segments ready for activation within days of engagement with no cost to build and no upfront fees prior to launch. Influencers are re-scored on a monthly basis to ensure ongoing accuracy, relevance and optimal outcomes. Segments can be activated across the widest variety of demand-side platforms (DSPs) in the industry for superior results rather than proprietary DSPs with secondary inventory.

About Swoop

Swoop (www.swoop.com), a Real Chemistry solution, empowers the world’s leading pharmaceutical brands to better educate patients about disease states and the therapies that could remedy their conditions, as well as enable them to become active participants in their treatment journey. Swoop’s HIPAA-certified and NAI-accredited system of activation has uncovered over 1,800 unique target audiences for precisely activating patient populations and their healthcare ecosystems through cross-channel marketing strategies. By utilizing artificial intelligence, machine learning and evolutionary computation in conjunction with a real-world data universe of over 300 million de-identified patients and 65 billion anonymized social determinants of health signals, Swoop's segments are superior in audience quality, lead to optimal conversion and drive increased Rx lift. It’s no wonder that 18 of the top 20 healthcare marketing agencies and 42 of the top 50 pharmaceutical brands power their marketing efforts with Swoop. And we are just getting started.

About Real Chemistry

Real Chemistry is a global health innovation company making the world a healthier place by empowering patients to access the right treatment at the right time, equitably and cost-effectively. We leverage best-in-class data-driven, tech-enabled and digital solutions to deliver clear, concise communications, engagement, activation and value across a full range of healthcare stakeholders – patients, payors, providers, caretakers and regulators. For more information, please visit www.realchemistry.com and connect with us on Twitter and LinkedIn.

Contacts

Peter Duckler
773-343-3069
pduckler@realchemistry.com

Real Chemistry


Release Summary
Swoop today announced the release of its newest product offerings that uncover optimal healthcare provider influencers for life sciences companies.
Release Versions

Contacts

Peter Duckler
773-343-3069
pduckler@realchemistry.com

Social Media Profiles
More News From Real Chemistry

SUO and Ferring Pharmaceuticals Announce the SUO Non-Muscle Invasive Bladder Cancer (NMIBC) Fellows Research Grant

SCHAUMBURG, Ill. & PARSIPPANY, N.J.--(BUSINESS WIRE)--The Society of Urologic Oncology (SUO) and Ferring Pharmaceuticals today announced the SUO NMIBC (non-muscle invasive bladder cancer) Fellows Research Grant, created to support outstanding clinical research investigators committed to advancing the understanding and treatment of NMIBC. Two applicants will receive the SUO NMIBC Fellows Research Grant, provided by an educational grant from Ferring Pharmaceuticals. “Advancing research in NMIBC i...

Real Chemistry Strengthens Media and Omnichannel Leadership with Acquisition of Spring & Bond

NEW YORK--(BUSINESS WIRE)--Real Chemistry continues to strengthen its media capabilities by acquiring Spring & Bond....

Real Chemistry Appoints Meenakshi Yadav as Chief AI Products and Solutions Officer

NEW YORK--(BUSINESS WIRE)--Real Chemistry announces Meenakshi Yadav as Chief AI Products and Solutions Officer, marking a strategic leap in its AI journey....
Back to Newsroom